Infarct Size as Assessed by Peak Enzyme Levels is Reduced in Patients Who are Using Angiotensin-Converting Enzyme Inhibitors at the Onset of Infarction
Dr Knud Landmark, Ivar AursnesVolume:
20
Language:
english
DOI:
10.2165/00044011-200020060-00004
Date:
December, 2000
File:
PDF, 195 KB
english, 2000